RO60784A2 - - Google Patents

Info

Publication number
RO60784A2
RO60784A2 RO7272272A RO7272272A RO60784A2 RO 60784 A2 RO60784 A2 RO 60784A2 RO 7272272 A RO7272272 A RO 7272272A RO 7272272 A RO7272272 A RO 7272272A RO 60784 A2 RO60784 A2 RO 60784A2
Authority
RO
Romania
Application number
RO7272272A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to RO7272272A priority Critical patent/RO60784A2/ro
Publication of RO60784A2 publication Critical patent/RO60784A2/ro

Links

RO7272272A 1972-11-03 1972-11-03 RO60784A2 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RO7272272A RO60784A2 (ro) 1972-11-03 1972-11-03

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RO7272272A RO60784A2 (ro) 1972-11-03 1972-11-03

Publications (1)

Publication Number Publication Date
RO60784A2 true RO60784A2 (ro) 1976-07-15

Family

ID=20091394

Family Applications (1)

Application Number Title Priority Date Filing Date
RO7272272A RO60784A2 (ro) 1972-11-03 1972-11-03

Country Status (1)

Country Link
RO (1) RO60784A2 (ro)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3050567A1 (en) * 2013-09-26 2016-08-03 Energenesis Biomedical Co., Ltd. Compound for activating ampk and uses thereof

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3050567A1 (en) * 2013-09-26 2016-08-03 Energenesis Biomedical Co., Ltd. Compound for activating ampk and uses thereof
EP3050567A4 (en) * 2013-09-26 2017-04-05 Energenesis Biomedical Co., Ltd. Compound for activating ampk and uses thereof
AU2013401767B2 (en) * 2013-09-26 2019-05-09 Energenesis Biomedical Co., Ltd Compound for activating ampk and uses thereof
AU2019203668B2 (en) * 2013-09-26 2020-09-10 Energenesis Biomedical Co., Ltd Compound for activating AMPK and uses thereof
EP3769766A1 (en) * 2013-09-26 2021-01-27 Energenesis Biomedical Co., Ltd. Adenine for activating ampk and their medical uses
AU2020244377B2 (en) * 2013-09-26 2022-04-07 Energenesis Biomedical Co., Ltd Compound for activating AMPK and uses thereof

Similar Documents

Publication Publication Date Title
FR2181072B1 (ro)
JPS49116761A (ro)
FR2189372B1 (ro)
JPS5229857B2 (ro)
FR2206526A1 (ro)
JPS515118B2 (ro)
JPS5437717B2 (ro)
JPS4939083A (ro)
JPS492164A (ro)
FR2169280A1 (ro)
JPS49104932U (ro)
RO60784A2 (ro)
JPS5225974Y2 (ro)
FR2172959B1 (ro)
FR2136571A5 (ro)
JPS503810B2 (ro)
JPS4943237U (ro)
JPS4891247U (ro)
JPS4982665U (ro)
JPS4987470A (ro)
CH591524A5 (ro)
CH581095A5 (ro)
CH594010A5 (ro)
CH593329A5 (ro)
NL7214646A (ro)